X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1671) 1671
Publication (179) 179
Book Review (29) 29
Book Chapter (9) 9
Newsletter (8) 8
Newspaper Article (3) 3
Dissertation (2) 2
Magazine Article (2) 2
Conference Proceeding (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1116) 1116
index medicus (908) 908
infectious diseases (584) 584
pharmacology & pharmacy (562) 562
carbapenems (557) 557
male (557) 557
microbiology (557) 557
female (495) 495
antibiotics (456) 456
microbial sensitivity tests (379) 379
anti-bacterial agents - therapeutic use (374) 374
middle aged (370) 370
anti-bacterial agents - pharmacology (367) 367
anti-bacterial agents - administration & dosage (365) 365
carbapenems - pharmacology (357) 357
aged (333) 333
adult (325) 325
carbapenems - administration & dosage (317) 317
infections (317) 317
carbapenems - therapeutic use (301) 301
drug resistance (295) 295
research (286) 286
bacteria (263) 263
carbapenem (250) 250
meropenem (249) 249
dosage and administration (241) 241
drug resistance in microorganisms (223) 223
risk factors (222) 222
epidemiology (214) 214
antimicrobial agents (208) 208
mortality (205) 205
pseudomonas-aeruginosa (205) 205
animals (203) 203
hospitals (198) 198
health aspects (196) 196
enterobacteriaceae (187) 187
treatment outcome (185) 185
pneumonia (175) 175
klebsiella-pneumoniae (174) 174
aged, 80 and over (168) 168
pharmacokinetics (168) 168
gram-negative bacteria (166) 166
drug resistance, bacterial (164) 164
carbapenems - pharmacokinetics (160) 160
escherichia-coli (160) 160
anti-bacterial agents - pharmacokinetics (157) 157
imipenem (157) 157
drug therapy (154) 154
nosocomial infections (153) 153
antimicrobial resistance (148) 148
colistin (147) 147
acinetobacter baumannii - drug effects (145) 145
biochemical phenomena, metabolism, and nutrition (144) 144
bacterial infections and mycoses (142) 142
medicine (142) 142
analysis (141) 141
bacteremia (141) 141
immunology (141) 141
resistance (140) 140
retrospective studies (140) 140
drug resistance, multiple, bacterial (137) 137
patients (137) 137
carbapenem resistance (133) 133
acinetobacter baumannii (132) 132
bacterial infections - drug therapy (130) 130
ventilator-associated pneumonia (128) 128
adolescent (124) 124
infection (124) 124
research article (124) 124
klebsiella pneumoniae - drug effects (123) 123
care and treatment (121) 121
polycyclic compounds (120) 120
pathogens (118) 118
risk-factors (117) 117
therapy (115) 115
thienamycins - administration & dosage (113) 113
tigecycline (113) 113
carbapenem-resistant enterobacteriaceae (109) 109
intensive care units (107) 107
drug therapy, combination (105) 105
pharmacology (105) 105
pseudomonas aeruginosa - drug effects (105) 105
surveillance (104) 104
anti-bacterial agents - adverse effects (101) 101
pseudomonas aeruginosa (101) 101
acinetobacter infections - drug therapy (99) 99
beta-lactam resistance (99) 99
critically-ill patients (99) 99
beta-lactamases - genetics (98) 98
infectious and parasitic diseases (98) 98
klebsiella infections - microbiology (95) 95
doripenem (94) 94
in-vitro activity (94) 94
cross infection - microbiology (93) 93
laboratories (93) 93
usage (93) 93
acinetobacter infections - microbiology (92) 92
beta-lactamases - metabolism (92) 92
child (92) 92
young adult (92) 92
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1599) 1599
Japanese (57) 57
French (8) 8
Russian (8) 8
Chinese (5) 5
Spanish (4) 4
Czech (2) 2
German (2) 2
Italian (2) 2
Korean (2) 2
Norwegian (1) 1
Polish (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Journal Article
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 02/2013, Volume 11, Issue 2, pp. 159 - 177
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2518 - 2523
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CHANGING EPIDEMIOLOGY | GLABRATA | THERAPY | ANTIFUNGAL AGENTS | NEUTROPHILS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | COLONIZATION | SULFAMETHOXAZOLE | OUTCOMES | ALBICANS | KRUSEI | Candida glabrata - physiology | Coinfection | Prospective Studies | Carbapenems - administration & dosage | Humans | Middle Aged | Bacteria - drug effects | Fluconazole - administration & dosage | Candidiasis - microbiology | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Bacteria - growth & development | Clindamycin - adverse effects | Candidiasis - drug therapy | Clindamycin - administration & dosage | Aged, 80 and over | Adult | Female | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Odds Ratio | Drug Resistance, Fungal | Bacterial Infections - microbiology | Candidemia - microbiology | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Bacterial Infections - drug therapy | Risk Factors | Colistin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Carbapenems - adverse effects | Candidiasis - etiology | Candidemia - drug therapy | Aged | Israel | Anti-Bacterial Agents - administration & dosage | Antifungal Agents - administration & dosage | Candidemia - etiology | Candida glabrata - drug effects | Drugs | Colistin | Clindamycin | Drug resistance | Risk factors | Infection | Antibiotics | azoles | trimethoprim-sulfamethoxazole | Models | Candidemia | Metronidazole | Carbapenems | Epidemiology and Surveillance
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 11, pp. 1380 - 1389
Journal Article
Journal Article
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 10/2011, Volume 9, Issue 10, pp. 909 - 922
The spread of resistance among Gram-positive and Gram-negative bacteria represents a growing challenge for the development of new antimicrobials. The pace of... 
ESBL | new classes of antimicrobials | new anti-Gram-negative compounds | MBL | ESCAPE | BACTERIA | ESCHERICHIA-COLI | CARBAPENEM | CEFTAZIDIME PLUS | COMPLICATED SKIN | PSEUDOMONAS-AERUGINOSA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | BETA-LACTAMASE INHIBITOR | CEFTAROLINE | IN-VITRO ACTIVITY | Polymyxins - therapeutic use | Carbapenems - administration & dosage | Humans | beta-Lactamases - administration & dosage | Monobactams - administration & dosage | Antimicrobial Cationic Peptides - administration & dosage | Protein Synthesis Inhibitors - administration & dosage | Indoles - administration & dosage | Monobactams - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Infection Control - organization & administration | Aminoglycosides - administration & dosage | Gram-Negative Bacteria - physiology | Drug Resistance, Multiple, Bacterial - physiology | Drug Administration Schedule | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | beta-Lactamases - therapeutic use | Drug Discovery | Antimicrobial Cationic Peptides - therapeutic use | Gram-Negative Bacteria - drug effects | Polymyxins - administration & dosage | Carbapenems - therapeutic use | Gram-Negative Bacteria - pathogenicity | Indoles - therapeutic use | Anti-Bacterial Agents - administration & dosage | Drug Resistance, Multiple, Bacterial - drug effects | Protein Synthesis Inhibitors - therapeutic use | Aminoglycosides - therapeutic use | Outer membranes | Antimicrobial agents | Protein biosynthesis | Drug development | Tides | Infection | Ribosomal subunits | Reviews | Antibiotics | Cephalosporins | Developmental stages | Tetracyclines | Antimicrobial peptides | Keys | Aminoglycoside antibiotics | Gram-negative bacteria | Carbapenems | Polymyxins
Journal Article
Critical Care Medicine, ISSN 0090-3493, 03/2011, Volume 39, Issue 3, pp. 560 - 570
OBJECTIVE:To address issues of antibiotic dosing during sustained low-efficiency dialysis by using available pharmacokinetic data, intermittent and continuous... 
dialysis | continuous renal replacement therapy | critical care | pharmacokinetics | sustained low-efficiency dialysis | anti-infectives | antibiotics | ACUTE KIDNEY INJURY | SLEDD-F | INTERMITTENT HEMODIALYSIS | SEPTIC PATIENTS | UREA KINETICS | HIGH-FLUX HEMODIALYSIS | EXTENDED DAILY DIALYSIS | INTENSIVE-CARE-UNIT | DAILY DIAFILTRATION | RENAL REPLACEMENT THERAPY | CRITICAL CARE MEDICINE | Critical Care - methods | Linezolid | Carbapenems - administration & dosage | Echinocandins - pharmacokinetics | Humans | Renal Dialysis - methods | Carbapenems - pharmacokinetics | Oxazolidinones - administration & dosage | Fluoroquinolones - pharmacokinetics | Peritoneal Dialysis, Continuous Ambulatory - adverse effects | Echinocandins - administration & dosage | Aminoglycosides - administration & dosage | Fluoroquinolones - administration & dosage | Vancomycin - administration & dosage | Acetamides - pharmacokinetics | Aminoglycosides - pharmacokinetics | Oxazolidinones - pharmacokinetics | Peritoneal Dialysis, Continuous Ambulatory - methods | Renal Insufficiency - therapy | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Renal Dialysis - adverse effects | Daptomycin - pharmacokinetics | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Acetamides - administration & dosage
Journal Article
Future Microbiology, ISSN 1746-0913, 09/2017, Volume 12, Issue 11, pp. 1001 - 1016
Antibiotics are often used in neonates despite the absence of relevant dosing information in drug labels. For neonatal dosing, clinicians must extrapolate data... 
aminoglycoside | β-lactams | drug dosing | carbapenem | anti-infective agents | pharmacokinetics | preterm | neonate | infant | cephalosporins | INTRAVENOUS METRONIDAZOLE | GLOMERULAR-FILTRATION | SCAVENGED SAMPLES | PREMATURE-INFANTS | MICROBIOLOGY | DEVELOPMENTAL PHARMACOKINETICS | CEFTAZIDIME PHARMACOKINETICS | beta-lactams | STAPHYLOCOCCUS-AUREUS INFECTIONS | POPULATION PHARMACOKINETICS | TISSUE DISTRIBUTION | CLINICAL-PRACTICE | beta-Lactams - pharmacokinetics | Birth Weight - drug effects | Glycopeptides - administration & dosage | Humans | Thienamycins - pharmacokinetics | Infant | Clindamycin - pharmacokinetics | Piperacillin - administration & dosage | Clindamycin - adverse effects | Aminoglycosides - administration & dosage | Clindamycin - administration & dosage | Metronidazole - adverse effects | Adult | Anti-Bacterial Agents - adverse effects | Glycopeptides - pharmacokinetics | Infant, Newborn - physiology | Thienamycins - adverse effects | Child | Penicillanic Acid - analogs & derivatives | Penicillanic Acid - administration & dosage | Body Size - drug effects | Medication Reconciliation | Thienamycins - administration & dosage | Aminoglycosides - pharmacokinetics | Metronidazole - administration & dosage | Cephalosporins - administration & dosage | Glycopeptides - adverse effects | Metronidazole - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | beta-Lactams - adverse effects | Aminoglycosides - adverse effects | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus
Journal Article
Journal Article